Cancer
fromwww.theguardian.com
7 hours agoGSK reports promising early results in ovarian and womb cancer drug trial
GSK's Mo-Rez treatment shows promising results in shrinking tumors for ovarian and endometrial cancers, leading to plans for late-stage trials.